Delivery Order SPE2DB22D1202-SPE2DB24FVHH7
Award Date
7/18/24
Potential Completion Date
7/19/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.64 firm fixed-price delivery order is for the supply of 50 ml vials of 1% Lidocaine HCL, a local anesthetic medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 1% vials, valued at $1,351.13, with a completion date of March 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This federal contract award is for the delivery of Lidocaine HCL 1% ampules to the Defense Logistics Agency (DLA). The $1,224.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
This federal contract award, valued at $6,379.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 2% 200 MG/10 ML 10ML, a medical product. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,702.82 firm fixed-price delivery order is for the supply of 4% Lidocaine HCL Ampul, 5 ML. The contract has an ultimate completion date of September 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,391.46, is for the delivery of 4,567,015,290 units of Lidocaine 1% 20ml 25s. The contract has a completion date of February 20, 2025 and is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,114.40 firm fixed-price delivery order is for the procurement of 4566619544 - Lidocaine HCL 5ML 25S medical supplies. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not designated with any set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine HCL 1% vials, a critical medical commodity. The contract has a ceiling value of $4,880.63 and a period of performance through January 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY6BT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,490,739 units of Lidocaine HCL 2% in 5mL vials, with a total ceiling value of $1,793.91. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 6, 2024. The contract was awarded on May 3, 2024, and was not designated...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FP5Q4) valued at $1,628.10 for the supply of Lidocaine HCL 2% in 5 mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of August 30, 2023 and is a firm fixed price agreement. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...